Supreme Court Report

Supreme Court of the United States · Official docket →

AstraZeneca Pharmaceuticals LP v. Suzanne Ivie

Paid petition · United States Court of Appeals for the Ninth Circuit, No. 21-35978 · judgment May 19, 2023


Certiorari denied · December 11, 2023
Pre-decision estimate: 12% cert probability (95% interval 9%–16%)

Before the decision, about 3× the 4.1% base rate. The model weighted this up for a Ninth Circuit decision below, a circuit split argued in the petition, and a dissent in the court below (flagged in the petition).

Question presented

In a final pretrial order under Rule 16, may a party generally contest whether the opposing party will satisfy its burden of proof on a claim or affirmative defense or must a party specifically identify each disputed element.

Counsel of record

For petitioner
Thomas M. Peterson
Morgan, Lewis & Bockius LLP

For respondent
Robert Scott Oswald
The Employment Law Group, PC

Case

Conference history
Distributed for 2 conferences

Proceedings

  1. Dec 11 2023
    Petition DENIED.
  2. Dec 01 2023
    Rescheduled.
  3. Dec 01 2023
    DISTRIBUTED for Conference of 12/8/2023.
  4. Nov 08 2023
    DISTRIBUTED for Conference of 12/1/2023.
  5. Nov 03 2023
    Waiver of right of respondent Suzanne Ivie to respond filed.
  6. Oct 16 2023
    Petition for a writ of certiorari filed. (Response due November 17, 2023)